The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia, Blood, vol.127, issue.20, pp.2391-405, 2016. ,
Next-generation evaluation and treatment of pediatric acute lymphoblastic leukemia, J Pediatr, vol.203, pp.14-24, 2018. ,
Mutational landscape of pediatric acute lymphoblastic leukemia, Cancer Res, vol.77, issue.2, pp.390-400, 2017. ,
TP53 Germline variations influence the predisposition and prognosis of B-cell acute lymphoblastic leukemia in children, J Clin Oncol, vol.36, issue.6, pp.591-600, 2018. ,
Blinded by the light: the growing complexity of p53, Cell, vol.137, issue.3, pp.413-444, 2009. ,
Human Oncoviruses and p53 Tumor Suppressor Pathway Deregulation at the Origin of Human Cancers, Cancers (Basel), vol.10, issue.7, p.213, 2018. ,
Regulation of MDM4, Front Biosci, vol.16, pp.1144-56, 2011. ,
, Mol Cancer Res, vol.2, issue.1, pp.1-8, 2004.
MDM4 is a key therapeutic target in cutaneous melanoma, Nat Med, vol.18, issue.8, pp.1239-1286, 2012. ,
MicroRNA control of p53, J Cell Biochem, vol.118, issue.1, pp.7-14, 2017. ,
MiR-125 in normal and malignant hematopoiesis, Leukemia, vol.26, issue.9, pp.2011-2019, 2012. ,
Biological functions of p53 isoforms through evolution: lessons from animal and cellular models, Cell Death Differ, vol.18, issue.12, pp.1815-1839, 2011. ,
URL : https://hal.archives-ouvertes.fr/ensl-00814713
p53 and its isoforms in cancer, Br J Cancer, vol.97, issue.3, pp.277-82, 2007. ,
URL : https://hal.archives-ouvertes.fr/inserm-00409543
p53 isoforms can regulate p53 transcriptional activity, Genes Dev, vol.19, issue.18, pp.2122-2159, 2005. ,
p53 isoforms regulate aging-and tumor-associated replicative senescence in T lymphocytes, J Clin Invest, vol.123, issue.12, pp.5247-57, 2013. ,
How many mutant p53 molecules are needed to inactivate a tetramer?, Mol Cell Biol, vol.24, issue.8, pp.3536-51, 2004. ,
p53 requires an intact C-terminal domain for DNA binding and transactivation, J Mol Biol, vol.415, issue.5, pp.843-54, 2012. ,
Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia, Nature, vol.446, issue.7137, pp.758-64, 2007. ,
Emerging patterns of somatic mutations in cancer, Nat Rev Genet, vol.14, issue.10, pp.703-721, 2013. ,
Effects of Delta40p53, an isoform of p53 lacking the N-terminus, on transactivation capacity of the tumor suppressor protein p53, BMC Cancer, vol.13, p.134, 2013. ,
URL : https://hal.archives-ouvertes.fr/hal-01261793
DeltaN-p53, a natural isoform of p53 lacking the first transactivation domain, counteracts growth suppression by wild-type p53, Oncogene, vol.21, issue.44, pp.6722-6730, 2002. ,
p53 isoforms Delta133p53 and p53beta are endogenous regulators of replicative cellular senescence, Nat Cell Biol, vol.11, issue.9, pp.1135-1177, 2009. ,
p53 isoforms regulate premature aging in human cells, Oncogene, vol.37, issue.18, pp.2379-93, 2018. ,
Delta133p53 represses p53-inducible senescence genes and enhances the generation of human induced pluripotent stem cells, Cell Death Differ, vol.24, issue.6, pp.1017-1045, 2017. ,
Senescence-associated reprogramming promotes cancer stemness, Nature, vol.553, issue.7686, pp.96-100, 2018. ,
URL : https://hal.archives-ouvertes.fr/hal-02364397
, Publisher's Note
, Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations